About this FactMed analysis covering adverse side effect reports of ZIDOVUDINE patients who developed ADRENALITIS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking ZIDOVUDINE reported ADRENALITIS to the FDA. A total of 6421 ZIDOVUDINE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ZIDOVUDINE and ADRENALITIS. In doing so, we compare ZIDOVUDINE with other drugs that cause ADRENALITIS, to help you evaluate whether or not ZIDOVUDINE causes ADRENALITIS. Likewise, this page shows the most highly-reported side effects of ZIDOVUDINE, so you can see if ADRENALITIS ranks among ZIDOVUDINE's most well-known side effects.
Summary Statistics
Reports of ZIDOVUDINE causing ADRENALITIS: 1
Reports of any side effect of ZIDOVUDINE : 6421
Percentage of ZIDOVUDINE patients where ADRENALITIS is a reported side effect: 0.0156%

FDA reports of any drug causing ADRENALITIS : 27
Average percentage for all medicated patients where ADRENALITIS is reported as a complication: 0.0002%

Physician opinion on ZIDOVUDINE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ZIDOVUDINE:
HIV INFECTION ( 2685 patients )
DRUG EXPOSURE DURING PREGNANCY ( 295 patients )
HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION ( 276 patients )
PROPHYLAXIS AGAINST HIV INFECTION ( 273 patients )
ANTIRETROVIRAL THERAPY ( 215 patients )
PROPHYLAXIS ( 214 patients )
ANTIVIRAL PROPHYLAXIS ( 212 patients )
DRUG USE FOR UNKNOWN INDICATION ( 163 patients )
ACQUIRED IMMUNODEFICIENCY SYNDROME ( 113 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 54 patients )
HIV TEST POSITIVE ( 49 patients )
ANTIVIRAL TREATMENT ( 33 patients )
MATERNAL EXPOSURE DURING PREGNANCY ( 25 patients )
SYSTEMIC ANTIVIRAL TREATMENT ( 21 patients )
VERTICAL INFECTION TRANSMISSION ( 17 patients )
MATERNAL EXPOSURE TIMING UNSPECIFIED ( 11 patients )
ILL-DEFINED DISORDER ( 10 patients )
VIRAL INFECTION ( 7 patients )
EXPOSURE TO COMMUNICABLE DISEASE ( 6 patients )
FOETAL EXPOSURE DURING PREGNANCY ( 5 patients )
RETROVIRAL INFECTION ( 5 patients )
HIV INFECTION CDC CATEGORY C3 ( 5 patients )
CD4 LYMPHOCYTES DECREASED ( 5 patients )
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY ( 5 patients )
ACUTE HIV INFECTION ( 4 patients )
INFECTION PROPHYLAXIS ( 3 patients )
MALARIA PROPHYLAXIS ( 3 patients )
HIV TEST ( 3 patients )
KAPOSI'S SARCOMA ( 3 patients )
HEPATITIS C VIRUS TEST ( 3 patients )
HEPATITIS C ( 2 patients )
HIV CARRIER ( 2 patients )
PATERNAL DRUGS AFFECTING FOETUS ( 2 patients )
HIV INFECTION CDC CATEGORY B3 ( 2 patients )
PNEUMOCYSTIS JIROVECI INFECTION ( 2 patients )
RENAL TRANSPLANT ( 2 patients )
HIV INFECTION CDC CATEGORY B2 ( 2 patients )
TROPICAL SPASTIC PARESIS ( 1 patients )
HIV INFECTION CDC CATEGORY A1 ( 1 patients )
ANTIFUNGAL PROPHYLAXIS ( 1 patients )
IMMUNOSUPPRESSION ( 1 patients )
HEPATITIS B ( 1 patients )
URTICARIA ( 1 patients )
ANTI-INFECTIVE THERAPY ( 1 patients )
NON-HODGKIN'S LYMPHOMA ( 1 patients )
PERINATAL HIV INFECTION ( 1 patients )
HIV INFECTION CDC CATEGORY C1 ( 1 patients )
PNEUMONIA ( 1 patients )
HIV INFECTION CDC GROUP I ( 1 patients )
CONGENITAL HIV INFECTION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with ADRENALITIS:

TRUVADA (7 patients)
VALGANCICLOVIR (6 patients)
DURAGESIC (6 patients)
METHOTREXATE (5 patients)
FOLIC ACID (5 patients)
ENBREL (5 patients)
BYETTA (4 patients)
COTRIM (4 patients)
FLUCONAZOLE (4 patients)
FAMOTIDINE (4 patients)
LOPINAVIR/RITONAVIR (3 patients)
URSODIOL (3 patients)
RIBAVIRIN (3 patients)
PEGASYS (3 patients)
AZITHROMYCIN (3 patients)
INCIVEK (3 patients)
DYAZIDE (2 patients)
VENOSTASIN (THIAMINE HYDROCHLORIDE, HORSE CHESTNUT EXTRACT) (2 patients)
VALGANCICLOVIR HCL (2 patients)
ADVAIR DISKUS 100/50 (2 patients)
SULFAMETHOXAZOLE AND TRIMETHOPRIM (2 patients)
DDAVP (2 patients)
FLOVENT (2 patients)
STEROIDS NOS (2 patients)
CYCLOSPORINE (2 patients)
GOLIMUMAB (2 patients)
SINGULAIR (2 patients)
BAKTAR (2 patients)
KALETRA (2 patients)
SEREVENT (2 patients)
LISINOPRIL (2 patients)
SANASTHMYL (BECLOMETASONE DIPROPIONATE) (2 patients)
LOPINAVIR AND RITONAVIR (2 patients)
ZOLOFT (2 patients)
METFORMIN HCL (2 patients)
AMITRIPTYLINE HYDROCHLORIDE (2 patients)
METOCLOPRAMIDE (2 patients)
MOVICOL (MACROGOL, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM BICARBO (2 patients)
NITROGLYCERIN (2 patients)
REGLAN (2 patients)
OXIS (FORMOTEROL) (2 patients)
PRILOSEC (2 patients)
ANTI-ASTHMATICS (2 patients)
OXYCODONE HCL (2 patients)
PANTOPRAZOLE SODIUM (2 patients)
OXYCODON KAPSELN 5MG(OXY IR CAPSULE 5 MG) (1 patients)
OXYCODON KAPSELN 5MG (OXY IR CAPSULE 5 MG)IR CAPSULE (1 patients)
RAMIPRIL (1 patients)
NORVIR (1 patients)
RETROVIR (1 patients)
AZITHROMYC (1 patients)
LOPINAVIR + RITONAVIR (LOPINAVIR + RITONAVIR) (1 patients)
SANDIMMUNE (1 patients)
LAMIVUDINE (1 patients)
IBUPROFEN (ADVIL) (1 patients)
DARUNAVIR ETHANOLATE (1 patients)
EPIVIR (1 patients)
DEPO-PROVERA (1 patients)
URSODEOXYCHOLIC ACID (1 patients)
ADRENOCORTICOTROPHIC HORMONE (1 patients)
ACETAMINOPHEN (1 patients)
EFFEXOR (1 patients)
EFALIZUMAB (1 patients)
ZIAGEN (1 patients)
ZIDOVUDINE (1 patients)
ABACAVIR (1 patients)
Most common side effects for patients taking ZIDOVUDINE:
DRUG EXPOSURE DURING PREGNANCY (1261 patients)
ANAEMIA (537 patients)
PYREXIA (389 patients)
PREMATURE BABY (377 patients)
IMMUNE RECONSTITUTION SYNDROME (368 patients)
DIARRHOEA (322 patients)
VOMITING (322 patients)
MATERNAL DRUGS AFFECTING FOETUS (305 patients)
NEUTROPENIA (302 patients)
NAUSEA (252 patients)
CAESAREAN SECTION (250 patients)
HIV INFECTION (226 patients)
HYPERLIPIDAEMIA (217 patients)
ALANINE AMINOTRANSFERASE INCREASED (213 patients)
DRUG INTERACTION (201 patients)
PREGNANCY (188 patients)
DEATH (186 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (175 patients)
LIPODYSTROPHY ACQUIRED (170 patients)
DRUG INEFFECTIVE (166 patients)
CARDIAC MURMUR (166 patients)
CONGENITAL ANOMALY (159 patients)
LYMPHADENOPATHY (155 patients)
RASH (153 patients)
HEPATIC FUNCTION ABNORMAL (150 patients)
LACTIC ACIDOSIS (144 patients)
PNEUMONIA (143 patients)
WEIGHT DECREASED (139 patients)
SEPSIS (136 patients)
BLOOD LACTIC ACID INCREASED (133 patients)
RENAL FAILURE ACUTE (133 patients)
DRUG RESISTANCE (131 patients)
HEADACHE (131 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (130 patients)
ABDOMINAL DISTENSION (127 patients)
COUGH (126 patients)
HAEMOGLOBIN DECREASED (125 patients)
PORTAL HYPERTENSION (124 patients)
HEPATOMEGALY (123 patients)
ASTHENIA (119 patients)
HYPERTENSION (113 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (112 patients)
ABDOMINAL PAIN (108 patients)
FATIGUE (108 patients)
STILLBIRTH (107 patients)
JAUNDICE (107 patients)
DRUG TOXICITY (107 patients)
HEPATOTOXICITY (107 patients)
THROMBOCYTOPENIA (106 patients)
DIZZINESS (106 patients)
DEHYDRATION (105 patients)
MITOCHONDRIAL TOXICITY (103 patients)
MALAISE (103 patients)
PANCYTOPENIA (101 patients)
NEONATAL DISORDER (100 patients)
DYSPNOEA (99 patients)
RENAL IMPAIRMENT (97 patients)
SMALL FOR DATES BABY (96 patients)
CACHEXIA (96 patients)
BLOOD BILIRUBIN INCREASED (96 patients)
PANCREATITIS (94 patients)
HYPERLACTACIDAEMIA (92 patients)
SUDDEN INFANT DEATH SYNDROME (90 patients)
CONVULSION (89 patients)
GASTROINTESTINAL DISORDER (88 patients)
HYPERTRIGLYCERIDAEMIA (88 patients)
ATRIAL SEPTAL DEFECT (88 patients)
EYELID PTOSIS (86 patients)
RESPIRATORY DISTRESS (83 patients)
MYOPATHY (82 patients)
LIPOATROPHY (80 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (80 patients)
HEPATITIS (80 patients)
VENTRICULAR SEPTAL DEFECT (79 patients)
CHOLESTASIS (78 patients)
DEATH NEONATAL (75 patients)
GASTROENTERITIS (74 patients)
HEPATIC ENCEPHALOPATHY (74 patients)
RENAL FAILURE (74 patients)
PALLOR (74 patients)
ACUTE HEPATIC FAILURE (73 patients)
METABOLIC ACIDOSIS (73 patients)
MATERNAL EXPOSURE DURING PREGNANCY (72 patients)
HYPOTONIA (69 patients)
BLOOD TRIGLYCERIDES INCREASED (69 patients)
VENTRICULAR HYPERTROPHY (67 patients)
PNEUMOCYSTIS JIROVECI PNEUMONIA (67 patients)
DIPLOPIA (67 patients)
VIRAL MUTATION IDENTIFIED (67 patients)
SPLENOMEGALY (66 patients)
ASCITES (66 patients)
INTRA-UTERINE DEATH (65 patients)
TACHYCARDIA (64 patients)
NEUROPATHY PERIPHERAL (63 patients)
DEVELOPMENTAL DELAY (63 patients)
TACHYPNOEA (63 patients)
PHARYNGITIS (63 patients)
LIVER FUNCTION TEST ABNORMAL (63 patients)
DISEASE RECURRENCE (62 patients)
LEUKOPENIA (62 patients)
HEPATIC FAILURE (62 patients)
LIVER DISORDER (62 patients)
CRYPTORCHISM (61 patients)
PREMATURE LABOUR (60 patients)
ANAEMIA NEONATAL (60 patients)
HEPATOSPLENOMEGALY (60 patients)
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (60 patients)
ORAL CANDIDIASIS (59 patients)
ANAEMIA MACROCYTIC (59 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (58 patients)
DRUG LEVEL INCREASED (58 patients)
CONDITION AGGRAVATED (58 patients)
CONGENITAL HEART VALVE DISORDER (58 patients)
OSTEONECROSIS (58 patients)
TRISOMY 21 (58 patients)
PAIN IN EXTREMITY (58 patients)
TUBERCULOSIS (58 patients)
FOETAL GROWTH RETARDATION (57 patients)
HERPES ZOSTER (57 patients)
DECREASED APPETITE (57 patients)
APNOEA (56 patients)
HYPOAESTHESIA (55 patients)
PREMATURE RUPTURE OF MEMBRANES (55 patients)
GRAFT DYSFUNCTION (55 patients)
TRANSPLANT REJECTION (55 patients)
PATENT DUCTUS ARTERIOSUS (54 patients)
HYPERSENSITIVITY (54 patients)
NERVOUS SYSTEM DISORDER (54 patients)
MYALGIA (54 patients)
CONFUSIONAL STATE (53 patients)
HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION (53 patients)
PULMONARY HYPERTENSION (53 patients)
TOXICITY TO VARIOUS AGENTS (52 patients)
ABDOMINAL HERNIA (51 patients)
ATRIOVENTRICULAR BLOCK COMPLETE (51 patients)
ANOREXIA (50 patients)
OESOPHAGEAL CANDIDIASIS (49 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (48 patients)
PLATELET COUNT DECREASED (48 patients)
BLOOD AMYLASE INCREASED (48 patients)
BLOOD CREATININE INCREASED (48 patients)
DEPRESSION (47 patients)
WHITE BLOOD CELL COUNT DECREASED (47 patients)
ENCEPHALOPATHY (47 patients)
KAPOSI'S SARCOMA (47 patients)
HYPOKALAEMIA (45 patients)
HYPOGLYCAEMIA (45 patients)
BLOOD HIV RNA INCREASED (44 patients)
TRANSAMINASES INCREASED (44 patients)
OVERDOSE (44 patients)
LYMPHADENITIS (44 patients)
DYSPHAGIA (44 patients)
SPEECH DISORDER (43 patients)
ABORTION SPONTANEOUS (43 patients)
HYPOSPADIAS (43 patients)
RESPIRATORY FAILURE (43 patients)
CALCULUS URINARY (43 patients)
CD4 LYMPHOCYTES DECREASED (43 patients)
LIVER TRANSPLANT (42 patients)
LIPASE INCREASED (41 patients)
EXOMPHALOS (40 patients)
VARICES OESOPHAGEAL (40 patients)
RENAL DISORDER (40 patients)
CREATININE RENAL CLEARANCE DECREASED (39 patients)
FOETAL EXPOSURE DURING PREGNANCY (39 patients)
HEPATITIS C (39 patients)
HYPERTONIA (39 patients)
MENTAL STATUS CHANGES (39 patients)
BLOOD CHOLESTEROL INCREASED (39 patients)
HYDROCEPHALUS (39 patients)
PRE-ECLAMPSIA (38 patients)
OCULAR ICTERUS (38 patients)
NEONATAL RESPIRATORY DISTRESS SYNDROME (38 patients)
CONGESTIVE CARDIOMYOPATHY (38 patients)
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (38 patients)
ABNORMAL BEHAVIOUR (37 patients)
NODULAR REGENERATIVE HYPERPLASIA (37 patients)
MENTAL DISORDER (37 patients)
MYOCARDIAL INFARCTION (37 patients)
BRADYCARDIA (37 patients)
RHABDOMYOLYSIS (37 patients)
PSYCHOMOTOR HYPERACTIVITY (36 patients)
PORTAL HYPERTENSIVE GASTROPATHY (36 patients)
AGITATION (36 patients)
DEEP VEIN THROMBOSIS (36 patients)
HEPATIC STEATOSIS (36 patients)
SUICIDAL IDEATION (36 patients)
CARDIAC ARREST (35 patients)
PAIN (35 patients)
DISTURBANCE IN ATTENTION (35 patients)
HEPATITIS B (35 patients)
ERYTHEMA (35 patients)
GAIT DISTURBANCE (34 patients)
HIV WASTING SYNDROME (34 patients)
POLYDACTYLY (34 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (34 patients)
ANXIETY (34 patients)
CHEST PAIN (33 patients)
MITOCHONDRIAL CYTOPATHY (33 patients)
TREATMENT NONCOMPLIANCE (33 patients)
PRODUCTIVE COUGH (33 patients)
MOBILITY DECREASED (33 patients)
MECONIUM STAIN (33 patients)
VIROLOGIC FAILURE (33 patients)
OEDEMA PERIPHERAL (32 patients)
HIV TEST POSITIVE (32 patients)
HEPATIC NECROSIS (32 patients)
MYCOBACTERIUM AVIUM COMPLEX INFECTION (32 patients)
GASTRIC ULCER (32 patients)
UMBILICAL CORD ABNORMALITY (32 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ZIDOVUDINE


Issue Description / Topic Timestamp
QUESTION
JAUNDICE
Zidovudion ;is cause of jaundice 2016-10-12 08:24:16

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about ADRENALITIS and ZIDOVUDINE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ZIDOVUDINE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ZIDOVUDINE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ZIDOVUDINE experts. If you are a healthcare provider experienced in prescribing ZIDOVUDINE, please register here.
giCould not connect: